An article discusses the controversy surrounding menopausal hormone treatment (MHT) and its potential role in preventing dementia. Michelle Peate, a reproductive health researcher, expresses confusion over conflicting messages about MHT, noting that while some claims are supported by research, others are labeled as misinformation. The World Health Organization (WHO) recently updated its guidelines, finding no clear evidence to support or oppose MHT for dementia prevention in women under 65, and conditionally recommending against it for those over 65. This contrasts with influencer-driven messaging promoting early MHT use to maintain brain health. Australian researcher Professor Martha Hickey, who contributed to the WHO review, states that there is no evidence supporting MHT's effectiveness for cognitive protection across all ages.
Bias read (Center): While the article addresses a medical and scientific debate, it presents balanced perspectives by citing both the WHO's findings and the influence of online misinformation. It does not overtly favor one side over another, instead highlighting the discrepancy between scientific consensus and popular,



